Researchers First To Image Biomarker Of Neurogenesis

Medical News Today (press release) - UK
"This method has immense clinical applications for treating MS,"
says Dr. Krupp. "Dr. Maletic-Savatic's approach is groundbreaking
in that it is fundamental to the prospect of stem cell therapy
for this debilitating disease."

The finding may also prove to be monumental in the diagnosis
and treatment of multiple sclerosis, Parkinson's disease,
depression, and other disorders of ...
See all stories on this topic
http://www.medicalnewstoday.com/articles/91147.php

Combination therapy including antibiotics may be beneficial for multiple sclerosis EurekAlert! Mon, 10 Dec 2007 1:19 PM PST A preliminary study suggests that combining a medication currently used to treat multiple sclerosis with an antibiotic may slow the progress of the disease, according to an article posted online today that will appear in the February 2008 print issue of Archives of Neurology, one of the JAMA/Archives journals.

New Drug Offering Hope For Multiple Sclerosis Patients WFTV 9 Orlando Mon, 10 Dec 2007 1:39 PM PST A new drug is showing promise and offering hope to the 400,000 people in the U.S. who suffer from multiple sclerosis. READ: Hope For MS VIDEO: New Drug Offering Hope For Multiple Sclerosis Patients

Drug Combo With Antibiotic May Slow MS Progression HealthDay via Yahoo! News Mon, 10 Dec 2007 12:59 PM PST MONDAY, Dec. 10 (HealthDay News) -- Combining an antibiotic with a medication currently used to treat multiple sclerosis may slow progression of the disease, according to researchers at the Louisiana State Health Sciences Center in Shreveport.

Antibiotics 'could help slow MS' BBC News Mon, 10 Dec 2007 4:36 PM PST Adding antibiotics to standard drug therapy may slow down the progress of multiple sclerosis, research suggests.

Combining antibiotic with interferon may benefit some MS patients: study The Canadian Press via Yahoo! Canada News Mon, 10 Dec 2007 1:26 PM PST A common antibiotic taken daily by multiple sclerosis patients who are on interferon treatment may be effective in helping some people with the disabling neurological condition, a small preliminary study suggests.

Treatment using antibiotic may help slow MS CTV.ca Mon, 10 Dec 2007 1:44 PM PST An experimental treatment for multiple sclerosis that uses an antibiotic along with a common MS medication may slow the progress of the disease, finds a preliminary study set to appear in the February 2008 issue of Archives of Neurology.

Tech Transfer Initiative Aims To Speed Development Of MS Treatments Medical News Today Mon, 10 Dec 2007 3:20 AM PST The National Multiple Sclerosis Society last week announced the creation of Fast Forward LLC, a technology transfer initiative aimed at translating promising laboratory discoveries into effective new treatments for MS sufferers. [click link for full article]

Positive CHMP Vote For Betaferon® Label To Include Disability Progression Delay In Patients With The Earliest Sign Of MS
Medical News Today Mon, 10 Dec 2007 1:18 AM PST
The Committee for Medicinal Products for Human Use (CHMP) has recommended to include new results from the landmark BENEFIT (BEtaferon in Newly Emerging multiple sclerosis For Initial Treatment) study in the Betaferon® (interferon beta-1b) label. The BENEFIT study has demonstrated a delay in disability progression with early Betaferon® treatment. [click link for full article]

Combination therapy including antibiotics may be beneficial for multiple sclerosis
EurekAlert! Mon, 10 Dec 2007 1:19 PM PST
A preliminary study suggests that combining a medication currently used to treat multiple sclerosis with an antibiotic may slow the progress of the disease, according to an article posted online today that will appear in the February 2008 print issue of Archives of Neurology, one of the JAMA/Archives journals.

New Drug Offering Hope For Multiple Sclerosis Patients WFTV 9 Orlando Mon, 10 Dec 2007 1:39 PM PST A new drug is showing promise and offering hope to the 400,000 people in the U.S. who suffer from multiple sclerosis. READ: Hope For MS VIDEO: New Drug Offering Hope For Multiple Sclerosis Patients

Drug Combo With Antibiotic May Slow MS Progression HealthDay via Yahoo! News Mon, 10 Dec 2007 12:59 PM PST MONDAY, Dec. 10 (HealthDay News) -- Combining an antibiotic with a medication currently used to treat multiple sclerosis may slow progression of the disease, according to researchers at the Louisiana State Health Sciences Center in Shreveport.

Antibiotics 'could help slow MS' BBC News Mon, 10 Dec 2007 4:36 PM PST Adding antibiotics to standard drug therapy may slow down the progress of multiple sclerosis, research suggests.

Combining antibiotic with interferon may benefit some MS patients: study The Canadian Press via Yahoo! Canada News Mon, 10 Dec 2007 1:26 PM PST A common antibiotic taken daily by multiple sclerosis patients who are on interferon treatment may be effective in helping some people with the disabling neurological condition, a small preliminary study suggests.

Treatment using antibiotic may help slow MS CTV.ca Mon, 10 Dec 2007 1:44 PM PST An experimental treatment for multiple sclerosis that uses an antibiotic along with a common MS medication may slow the progress of the disease, finds a preliminary study set to appear in the February 2008 issue of Archives of Neurology.

Tech Transfer Initiative Aims To Speed Development Of MS Treatments Medical News Today Mon, 10 Dec 2007 3:20 AM PST The National Multiple Sclerosis Society last week announced the creation of Fast Forward LLC, a technology transfer initiative aimed at translating promising laboratory discoveries into effective new treatments for MS sufferers. [click link for full article]

Positive CHMP Vote For Betaferon® Label To Include Disability Progression Delay In Patients With The Earliest Sign Of MS
Medical News Today Mon, 10 Dec 2007 1:18 AM PST
The Committee for Medicinal Products for Human Use (CHMP) has recommended to include new results from the landmark BENEFIT (BEtaferon in Newly Emerging multiple sclerosis For Initial Treatment) study in the Betaferon® (interferon beta-1b) label. The BENEFIT study has demonstrated a delay in disability progression with early Betaferon® treatment. [click link for full article]